FDA approves La Jolla’s low blood pressure drug

Published 6y ago

(Reuters) – La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure. The company said it plans to make Giapreza available for patients in the United States in March... More »